Two Sigma Advisers
BLUE

Two Sigma Advisers’s bluebird bio BLUE Stock Holding History

Two Sigma Advisers’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,655
Closed -$370K – 2350
2024
Q3 		$370K Sell
35,655
-6,655
-16% -$111K ﹤0.01% 1833
2024
Q2 		$833K Sell
42,310
-15,730
-27% -$315K ﹤0.01% 1646
2024
Q1 		$1.49M Buy
58,040
+39,610
+215% +$1.02M ﹤0.01% 1375
2023
Q4 		$509K Buy
+18,430
New +$1.12M ﹤0.01% 1917
2023
Q1 		– Sell
-1,520
Closed -$210K – 2596
2022
Q4 		$210K Sell
1,520
-50
-3% -$7.04K ﹤0.01% 2172
2022
Q3 		$199K Sell
1,570
-10,550
-87% -$1.19M ﹤0.01% 2201
2022
Q2 		$1M Sell
12,120
-15,040
-55% -$1.17M ﹤0.01% 1593
2022
Q1 		$2.63M Buy
27,160
+23,490
+640% +$3.1M 0.01% 1094
2021
Q4 		$733K Buy
+3,670
New +$866K ﹤0.01% 1724
2021
Q2 		– Sell
-5,288
Closed -$2.06M – 2459
2021
Q1 		$2.06M Sell
5,288
-8,330
-61% -$4.1M 0.01% 1249
2020
Q4 		$7.63M Sell
13,618
-5,072
-27% -$3.21M 0.02% 661
2020
Q3 		$13.1M Buy
18,690
+8,585
+85% +$6.7M 0.04% 449
2020
Q2 		$7.99M Buy
10,105
+1,451
+17% +$1.09M 0.02% 634
2020
Q1 		$5.15M Sell
8,654
-31
-0.4% -$30.2K 0.02% 705
2019
Q4 		$9.87M Buy
+8,685
New +$9.44M 0.02% 602
2019
Q1 		– Sell
-3,412
Closed -$4.38M – 2302
2018
Q4 		$4.38M Buy
+3,412
New +$5.23M 0.01% 846
2018
Q2 		– Sell
-19,393
Closed -$42.9M – 2367
2018
Q1 		$42.9M Sell
19,393
-16,312
-46% -$41.5M 0.12% 225
2017
Q4 		$82.4M Buy
35,705
+34,555
+3,005% +$70.2M 0.22% 121
2017
Q3 		$2.05M Buy
1,150
+640
+125% +$894K 0.01% 1189
2017
Q2 		$693K Buy
+510
New +$615K ﹤0.01% 1673
2015
Q4 		– Sell
-1,058
Closed -$1.78M – 1873
2015
Q3 		$1.78M Sell
1,058
-4,099
-79% -$7.47M 0.01% 771
2015
Q2 		$11.2M Buy
5,157
+4,786
+1,290% +$9.75M 0.08% 279
2015
Q1 		$580K Sell
371
-779
-68% -$1.03M ﹤0.01% 1282
2014
Q4 		$1.37M Buy
+1,150
New +$768K 0.01% 1002

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Two Sigma Advisers's BLUE Position: Q4 2024 in Review

Two Sigma Advisers sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 35,655 shares — an estimated $370K sold.

Two Sigma Advisers first reported a position in BLUE in Q4 2014 and held it in 24 quarters. The position peaked at $82.4M in Q4 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Two Sigma Advisers reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 35,655 bluebird bio shares in Q4 2024, an estimated $370K.
  • Two Sigma Advisers first reported a position in bluebird bio in Q4 2014 and held it in 24 quarters.
  • Two Sigma Advisers's bluebird bio position peaked at $82.4M in Q4 2017.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.